Pain control after thyroid surgery

Ultrasound-guided capsule-sheath block for postoperative pain after thyroid surgery - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054897

Enrollment

Registered

2023-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E079- Disorder of thyroid, unspecified

Interventions

Intervention1: ultrasound guided capsule sheath block: US CSB given to patients undergoing thyroidectomy with 10 ml of Levo bupivacaine 0.25% Observed at 30 min, 60 min, 4 , 8 and 12 hours after surge

Eligibility

Inclusion criteria

Inclusion criteria: a. Patient aged above 18 years b. Patients planned for thyroid or parathyroid surgery.

Exclusion criteria

Exclusion criteria: a. Patient refusal b. Thyroid gland diameter more than 8 cm c. Retrosternal goitre d. Anticipated lymph node dissection e. Patients on beta blockers f. Allergy to local anaesthetics. g. Patients with a history of bronchial asthma h. Patients with renal impairment (eGFR less than 30 ml/min/1.73 m2)

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing VAS scores at 4 hours after thyroid surgery.Timepoint: Checked at 4 hours after surgery.	—

Secondary

Measure	Time frame
1) To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing VAS scores at 30 min, 8 & 12 hours after surgery 2) To evaluate the efficacy of ultrasound-guided capsule-sheath block in decreasing the time to first analgesic use postoperatively. 3) To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing total analgesic use in the first 12 hours after surgery. 4) To evaluate the postoperative side effects of ultrasound-guided capsule-sheath block. Timepoint: 30min, 8 & 12 hrs after surgery	—

Measure

Time frame

1) To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing VAS scores at 30 min, 8 & 12 hours after surgery 2) To evaluate the efficacy of ultrasound-guided capsule-sheath block in decreasing the time to first analgesic use postoperatively. 3) To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing total analgesic use in the first 12 hours after surgery. 4) To evaluate the postoperative side effects of ultrasound-guided capsule-sheath block. Timepoint: 30min, 8 & 12 hrs after surgery

—

Countries

India

Contacts

Public ContactSeathe Banga

Max Super Specilaity Hospital

drnambiath@yahoo.com9999109402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026